High frequency of macrolide resistance mechanisms in clinical isolates of Corynebacterium species

Microbial Drug Resistance

Volumn 16, Issue 4, 2010, Pages 273-277

  Ortiz Pérez, Alberto ^a   Martín De Hijas, Nieves Z ^a   Esteban, Jaime ^a   Fernández Natal, María Isabel ^b   García Cía, José Ignacio ^c   Fernández Roblas, Ricardo ^a  

^a Instituto de Investigación Sanitaria Fundación Jiménez Díaz   (Spain)

^b SACYL ^*  (Spain)

^c Clinical Microbiology Laboratory   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; MACROLIDE; SPIRAMYCIN; STREPTOGRAMIN DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CORYNEBACTERIUM; CORYNEBACTERIUM AFERMENTANS; CORYNEBACTERIUM AMYCOLATUM; CORYNEBACTERIUM AURIMUCOSUM; CORYNEBACTERIUM COYLEAE; CORYNEBACTERIUM JEIKEIUM; CORYNEBACTERIUM STRIATUM; CORYNEBACTERIUM UREALYTICUM; HYDROLYSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CORYNEBACTERIUM; CORYNEBACTERIUM INFECTIONS; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; HUMANS; MACROLIDES; METHYLTRANSFERASES; MICROBIAL SENSITIVITY TESTS; SPECIES SPECIFICITY;

CORYNEBACTERIUM; CORYNEBACTERIUM AFERMENTANS SUBSP. AFERMENTANS; CORYNEBACTERIUM AMYCOLATUM; CORYNEBACTERIUM AURIMUCOSUM; CORYNEBACTERIUM COYLEAE; CORYNEBACTERIUM JEIKEIUM; CORYNEBACTERIUM SP.; CORYNEBACTERIUM STRIATUM; CORYNEBACTERIUM UREALYTICUM;

EID: 78650145727     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2010.0032     Document Type: Article

References (33)

1. Aktas, Z., A. Aridogan, C.B. Kayacan, and D. Aydin. 2007. Resistance to macrolide, lincosamide and streptogramin antibiotics in staphylococci isolated in Istanbul, Turkey. J. Microbiol. 45:286-290.
2. Bernard, K.A., C. Munro, D. Wrebe, and E. Ongsansoy. 2002. Characteristics of rare or recently described Corynebacterium species recovered from human clinical material in Canada. J. Clin. Microbiol. 40:4375-4381.
3. Canu, A., B. Malbruny, M. Coquemont, T.A. Davies, P.C. Appelbaum, and R. Leclercq. 2002. Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 46:125-131.
4. [CLSI] Clinical and Laboratory Standards Institute. 2006. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria; approved guideline. CLSI, Wayne, PA.
5. [CLSI] Clinical and Laboratory Standards Institute. 2007. Performance standards for antimicrobial susceptibility testing; seventeenth informational supplement. CLSI, Wayne, PA.
6. Daly, M.M., S.Z. Doktor, R.K. Flamm, and V.D. Shortridge. 2004. Characterization and prevalence of MefA, MefE, and the associated msr(D) gene in Streptococcus pneumonia clinical isolates. J. Clin. Microbiol. 42:3570-3574.
7. Daurel, C., C. Huet, A. Dhalluin, M. Bes, J. Etienne, and R. Leclercq. 2008. Differences in potential for selection of clindamycin-resistant mutants between inducible erm(A) and erm(C) Staphylococcus aureus genes. J. Clin. Microbiol. 46:546-550.
8. Davies, T.A., K. Bush, D. Sham, and A. Evangelista. 2005. Predominance of 23S rRNA mutants among non-erm, nonmef macrolide-resistant clinical isolates of Streptococcus pneumoniae collected in the United States in 1999-2000. Antimicrob. Agents Chemother. 49:3031-3033.
9. Esteban, J., E. Nieto, R. Calvo, R. Fernández-Roblas, P.L. Valero-Guillén, and F. Soriano. 1999. Microbiological characterization and clinical significance of Corynebacterium amycolatum strains. Eur. J. Clin. Microbiol. Infect. Dis. 18:18-21.
10. Fernández-Natal, M.I., J.A. Sáez-Nieto, R. Fernández- Roblas, M. Asencio, S. Valdezate, S. Lapeñ a, R.H. Rodri guez-Pollán, J.M. Guerra, J. Blanco, F. Cachó n, and F. Soriano. 2008. The isolation of Corynebacterium coyleae from clinical samples: clinical and microbiological data. Eur. J. Clin. Microbiol. Infect. Dis. 27:177-184.
11. Fernández-Roblas, R., H. Adames, N.Z. Martín-de-Hijas, D. García Almeida, I. Gadea, and J. Esteban. 2009. In vitro activity of tigecycline and 10 other antimicrobials against clinical isolates of the genus Corynebacterium. Int. J. Antimicrob. Agents 33:453-455.
12. Fernández-Roblas, R., S. Prieto, M. Santamaría, C. Ponte, and F. Soriano. 1987. Activity of nine antimicrobial agents against Corynebacterium group D2 strains isolated from clinical specimens and skin. Antimicrob. Agents Chemother. 31:821-822.
13. Funke, G., A. von Gravenitz, J.E. Clarridge, and K.A. Bernard. 1997. Clinical microbiology of coryneform bacteria. Clin. Microbiol. Rev. 10:125-159.
14. Funke, G., F.N. Renaud, J. Freney, and P. Riegel. 1997. Multicenter evaluation of the updated and extended API (RAPID) Coryne database 2.0. J. Clin. Microbiol. 35:3122-3126.
15. Goldstein, E.J., D.M. Citron, Y.C. Merriam, Y.A. Warren, K.L. Tyrrel, and H.T. Fernández. 2003. In vitro activities of daptomycin, vancomycin, quinupristin-dalfopristin, linezolid, and five other antimicrobials against 307 grampositive anaerobic and 31 Corynebacterium clinical isolates. Antimicrob. Agents Chemother. 47:337-341.
16. Gómez-Garcé s, J.L., J.I. Aló s, and J. Tamayo. 2007. In vitro activity of linezolid and 12 other antimicrobials against coryneform bacteria. Int. J. Antimicrob. Agents 29:688-692.
17. Luna, V.A., P. Coates, E.A. Eady, J.H. Cove, T.T. Nguyen, and M.C. Roberts. 1999. A variety of gram-positive bacteria carry mobile mef genes. J. Antimicrob. Chemother. 44:19-25.
18. Nakajima, Y. 1999. Mechanisms of bacterial resistance to macrolide antibiotics. J. Infect. Chemother. 5:61-74.
19. Ojo, K.K., M.J. Striplin, C.C. Ulep, N.S. Close, J. Zittle, H. Luis, M. Bernardo, J. Leitao, and M.C. Roberts. 2006. Staphylococcus efflux msr(A) gene characterized in Streptococcus, Enterococcus, Corynebacterium, and Pseudomonas isolates. Antimicrob. Agents Chemother. 50:1089-1091.
20. Renom, F., M. Garau, M. Rubí, F. Ramis, A. Galmé s, and J.B. Soriano. 2007. Nosocomial outbreak of Corynebacterium striatum infection in patients with chronic obstructive pulmonary disease. J. Clin. Microbiol. 45:2064-2067.
21. Riebel, W., N. Frantz, D. Adelstein, and P.J. Spagnuolo. 1986. Corynebacterium JK: a cause of nosocomial devicerelated infection. Rev. Infect. Dis. 8:42-49.
22. Roberts, M.C., J. Sutcliffe, P. Courvalin, L.B. Jensen, J. Rood, and H. Seppala. 1999. Nomenclature for macrolide and macrolide-lincosamide- streptogramin B resistance determinants. Antimicrob. Agents Chemother. 43:2823-2830.
23. Rosato, A.E., B.S. Lee, and K.A. Nash. 2001. Inducible macrolide resistance in Corynebacterium jeikeium. Antimicrob. Agents Chemother. 45:1982-1989.
24. Soriano, F., C. Ponte, and M.J. Galiano. 1993. Adherence of Corynebacterium urealyticum (CDC group D2) and Corynebacterium jeikeium to intravascular and urinary catheters. Eur. J. Clin. Microbiol. Infect. Dis. 12:453-456.
25. Soriano, F., J. Zapardiel, and E. Nieto. 1995. Antimicrobial susceptibilities of Corynebacterium species and other nonspore- forming gram-positive bacilli to 18 antimicrobial agents. Antimicrob. Agents Chemother. 39:208-214.
26. Soriano, F., J.M. Aguado, C. Ponte, R. Fernández-Roblas, and J.L. Rodríguez-Tudela. 1990. Urinary tract infection caused by Corynebacterium group D2. Report of 82 cases and review. Rev. Infect. Dis. 12:1019-1034.
27. Soriano, F., R. Fernández-Roblas, R. Calvo, and G. García- Calvo. 1998. In vitro susceptibilities of aerobic and facultative non-spore-forming gram positive bacilli to HMR 3647 (RU 66647) and 14 other antimicrobials. Antimicrob. Agents Chemother. 42:1028-1033.
28. Soriano Garcia, F., J.L. Rodríguez-Tudela, R. Fernández- Roblas, J.M. Aguado, and M. Santamaría. 1988. Skin colonization by Corynebacterium groups D2 and JK in hospitalized patients. J. Clin. Microbiol. 26:1878-1880.
29. Sutcliffe, J., T. Grebe, A. Tait-kamradt, L. Wondrack, and T. Grebe. 1996. Detection of erythromycin-resistant determinants by PCR. Antimicrob. Agents Chemother. 40: 2562-2566.
30. Tait-kamradt, A., T.A. Davies, M. Cronan, M.R. Jacobs, P.C. Appelbaum, and J. Sutcliffe. 2000. Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage. Antimicrob. Agents Chemother. 44:2118-2125.
31. Wondrack, L., M. Massa, V. Yang, and J. Sutcliffe. 1996. Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides. Antimicrob. Agents Chemother. 40: 992-998.
32. Yagü e, G., B. Mora, M.C. Martínez-Toldos, T. Rodríguez, P.L. Valero, and M. Segovia. 2005. Implication or ermX genes in macrolide- and telithromycin-resistance in Corynebacterium jeikeium and Corynebacterium amycolatum. Rev. Esp. Quimioter. 18:236-242.
33. Yao, J.D.C., and R.C. Moellering. 2007. Antimicrobial agents. In P.R. Murray, E.J. Baron, J.H. Jorgensen, M.L. Landry, and M.A. Pfaller (eds.), Manual of Clinical Microbiology, 9th edition, vol. 1. ASM Press, Washington, DC, pp. 1077-1113.